For the quarter ending 2025-09-30, BGMS made $81,000 in revenue. -$2,503,000 in net income. Net profit margin of -3090.12%.
| Income Statement | 2025-09-30 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues | 81,000 | 10,750 | ||
| Cost of sales | 64,000 | - | ||
| Research and development | 5,000 | 1,663,750 | ||
| General and administrative | 1,004,000 | 1,348,000 | ||
| Total operating expenses | 1,073,000 | 3,011,750 | ||
| Operating loss | -992,000 | -3,001,000 | ||
| Foreign exchange gains (losses) | -14,000 | -13,500 | ||
| Interest income | - | 3,000 | ||
| Interest income (expense) | 9,000 | - | ||
| Other income, net | 9,000 | 13,000 | ||
| Total other income, net | 4,000 | 2,500 | ||
| Loss before taxes | -988,000 | -2,998,500 | ||
| Income tax benefit | - | -195,500 | ||
| Net loss | -988,000 | -2,803,000 | ||
| Dividend on convertible exchangeable preferred shares | 21,000 | - | ||
| Deemed dividend on warrant exchange | -1,494,000 | - | ||
| Net loss applicable to common shareholders | -2,503,000 | -2,803,000 | ||
| Net loss per share - basic (common shareholders) | -1.31 | -126.075 | ||
| Net loss per share, diluted | -1.31 | -126.075 | ||
| Weighted average common shares outstanding - basic | 1,912,495 | 5,578,500 | ||
| Weighted average common shares outstanding - diluted | 1,912,495 | 5,578,500 | ||
Bio Green Med Solution, Inc. (BGMS)
Bio Green Med Solution, Inc. (BGMS)